Iain S. McGregor

Also affiliated with UNSW Sydney, Cooperative Trials Group for Neuro-Oncology, Io Therapeutics (United States)

MedicineNeurosciencePharmacology, Toxicology and PharmaceuticsPsychology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “In vitro and in vivo pharmacological evaluation of the synthetic cannabinoid receptor agonist EG-018”.

In vitro and in vivo pharmacological evaluation of the synthetic cannabinoid receptor agonist EG-018

Pharmacology Biochemistry and Behavior(2020)10.1016/j.pbb.2020.172918

N/A

0DataRank · unranked

17 citations

Daniel G. Barrus, Richard C. Kevin, David B. Finlay, Timothy W. Lefever, Purvi R. Patel +6 more

Gain-of-function GABRB3 variants identified in vigabatrin-hypersensitive epileptic encephalopathies

Brain Communications(2020)10.1093/braincomms/fcaa162

N/A

0DataRank · unranked

35 citations

Vivian W. Y. Liao, Kavitha Kothur, Dinesh C. Indurthi, Bruce Bennetts, Christopher Troedson +16 more

Cannabigerolic acid, a major biosynthetic precursor molecule in cannabis, exhibits divergent effects on seizures in mouse models of epilepsy

British Journal of Pharmacology(2021)10.1111/bph.15661

N/A

0DataRank · unranked

64 citations

Marika Heblinski, Nathan L. Absalom, Nicole A. Hawkins, Michael T. Bowen, Melissa J. Benson +8 more